Pharmaceutical compositions for treating oestrogenic deficiencies in Menopause and for the Prevention of Osteoporosis in postmenopausal women

摘要

A pharmaceutical component for the treatment of menopausal estrogen deficiency includes an estrogen component, including (I) 0.5-3 mg of free estrogen, estradiol infertility and (II) 1.5-3 mg of estrogen in the estrogen plasma group. 75 mg of ephedrine acetic acid and (3) a premedical disinfectant suitable for oral administration. A drug ingredient for the prevention of osteoporosis in menopausal women, including an estrogen ingredient, selected from a group of free estrogens, ranging from 0.5 mg to 3 mg.esterified estradiol and equine conjugated estrogens, (ii) from 1.5 to 3.75 mg of nomegestrol acetate and (iii) pharmaceutical excipients suitable for oral administration.